Skip to main content
NIH funding notice RFA-NS-21-025

NIH Blueprint for Neuroscience Research Short Courses in Neurotherapeutics Development (R25 Clinical Trial Not Allowed)

Closed on December 9, 2021.

Posted
October 15, 2021
Close date
December 9, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
1
1 new
First-year cost
$270,000
Institutions
1
1 contact PI

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. UNIVERSITY OF CALIFORNIA AT DAVIS1

Most frequent study sections

  1. Neurological Sciences and Disorders B (NSD-B)1
1 award under RFA-NS-21-025 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2022Training in Neurotherapeutics for Academic Scientists1R25NS129110-01Rogawski, Michael A.Slusher, Barbara StauchUNIVERSITY OF CALIFORNIA AT DAVIS, CAFirst-year cost $270,000Study section NSD
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-15-0.3.4. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.